secwatch.observer — SEC 8-K summary
======================================

Issuer:     XOMA Royalty Corp (XOMA)
CIK:        0000791908
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001193125-23-138911
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA Q1 2023 revenue drops to $0.4M; net loss widens to $9.8M; acquires IXINITY stream
--------------------------------------------------------------------------------

- Total revenue of $0.4M in Q1 2023 vs $3.1M in Q1 2022; no milestone revenue recognized.
- Net loss of $9.8M ($2.3M loss in Q1 2022) including $4.1M arbitration settlement costs.
- Cash and equivalents $44.3M at March 31, 2023; no debt; operating cash burn $4.9M.
- Acquired IXINITY commercial payment stream from Aptevo in March 2023; payments to begin Q2 2023.
- Received second commercial payment from Roche for Vabysmo (faricimab) in February 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/791908/000119312523138911/0001193125-23-138911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/791908/000119312523138911/d450885d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-138911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer